An observational study in HIV Infection, Prep Prescription and Vaccinations, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-19.
Sponsored by University Hospital, Strasbourg, France · Observational
Primary purpose of the study: to describe sexual behavior of Prep users, whatever mode of intake, ie continuous or on-demand; it has been shown in some studies, an increase of sexual risks in Prep users, and therefore an similar increase of STIs (sexually transmitted diseases); using a self-questionnaire, we'd like to evaluate sexual behavior before, and 6 months after, starting Prep.
Secondary purposes: to describe medical characteristics of Prep users (past medical condition, demographic characteristics, vaccinations, kidney function, serological results, urine and anal/pharyngeal swabs), clinical and biological Prep safety, STIs occurrence, and antibiotic prescriptions, continuous or on-demand intake, Prep indication.
424 studies on the registry are indexed under Sexually Transmitted Diseases; 71 are open to participants now.
This study's enrollment of 200 is below the median of 513 across 74 observational studies indexed under Sexually Transmitted Diseases.
Browse Sexually Transmitted Diseases studies →University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Non HIV-infected subjects, who have a high risk to be infected by HIV, mostly because of non protected sexual intercourse.
Most of them are MSM (men who have sex with men). And who started Prep (emtricitable/tenofovir disoproxil fumarate), or will initiate Prep
Exclusion criteria:
Define the behavioral characteristics of the active file of patients using PrEP in Strasbourg in 2019.
Analysis of sexual behavior in Prep users
Sexual behavior will be evaluated with a questionnaire
Time frame: 6 months
Description of the medical profile of the Strasbourgeoise active file
Describe the active line of people using Prep and followed in the center
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sexually Transmitted Diseases→
University Hospital, Strasbourg, France